Cancer Research UK logo.
SearchDonate
  • Search

A study of lanreotide for neuroendocrine tumours of the pancreas or small bowel that have spread (PRODIGE 31, REMINET)

Overview

Cancer types:

Neuroendocrine tumour (NET)

Status:

Closed

Phase:

Phase 2/3

Details

This study is for people with a neuroendocrine tumour that started in the pancreas or small bowel (duodenum) and cannot be removed with surgery.

Recruitment start: 1 September 2014

Recruitment end: 30 September 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Juan Valle

Supported by

Federation Francophone de Cancerologie Digestive (FFCD)

Ipsen

NIHR Clinical Research Network: Cancer

Last reviewed: 30 September 2018

CRUK internal database number: 13021

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.